Latest Asx Reinstatement News

Nova Minerals Corp. (ASX: NVA) has had its trading suspension lifted as of 18 June 2026, following the implementation of shareholder and warrant holder schemes of arrangement.

Elanor Investors Group has finalised a $125 million recapitalisation that slashes its cost of capital and reduces debt, setting the stage for a leaner, capital-light funds management model and imminent ASX reinstatement.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

NT Minerals has launched a pro-rata non-renounceable entitlement offer aiming to raise up to $968,722 at $0.002 per share, providing shareholders a chance to subscribe for two shares for every five held. The offer opened on 5 May 2026 and closes on 26 May 2026, with electronic access to prospectus documents and a focus on reducing paper usage.

Jayride Group continues its pivot to a SaaS mobility platform across Australasia and Southeast Asia, managing tight cash flow and planning a capital raise to sustain operations and support ASX reinstatement.

NT Minerals Limited aims to raise up to $968,722 through a pro-rata entitlement offer and complete the acquisition of Slipstream Paynes Find, a move critical to meeting ASX reinstatement conditions and funding exploration in Western Australia.

NT Minerals targets ASX reinstatement by acquiring the Endeavour Project via Slipstream Paynes Find, backed by a $810,000 entitlement offer and a planned share consolidation.

DGL Group Limited (ASX: DGL) posted a statutory net loss of $12.8 million for the half year ended December 2025, impacted by non-cash write downs and operational costs, while progressing strategic initiatives including warehouse expansion and a new liquid waste treatment plant.

Elanor Investors Group posted a net loss after tax of $13.8 million for the half year ended 31 December 2025, with no interim distribution declared. The group is progressing a strategic recapitalisation with Rockworth Capital Partners to strengthen its balance sheet amid ongoing financial challenges and material uncertainty about its ability to continue as a going concern.

Lithium Energy Limited has revealed a detailed two-year, $36 million plan to advance its battery minerals projects, supported by a robust $68 million cash position as it prepares for ASX relisting.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.